← Leaderboards
Paul Pearson
$61,600
Attributed
$61,600
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $48.4K · FY2021–22$50K$37.5K$25K$12.5K$0
'21
'22
Funding mix
By agency
NIH$61,600 · 1
By mechanism
N02$61,600 · 1
Top collaborators
No co-investigators on record.
Others in their field
Other Emerging Leaders on “Assay Development”
- Leonard Freedman · Leidos Biomedical Research, Inc.$296,496,694
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$238,974,575
- Lynn Briscoe · Leidos Biomedical Research, Inc.$142,638,338
- Yunda Huang · Fred Hutchinson Cancer Center$72,814,726
- Ted Ross · University Of Georgia$68,763,143
- Leonard Freedmand · Leidos Biomedical Research, Inc.$59,575,656
Research focus
Assay DevelopmentChemistryClinical ResearchConsultConsultationsContractorData AnalysesDesignDrug DevelopmentDrug DiscoveryDrug KineticsDrug MetabolismExperimental DesignsFormulationLeadLead OptimizationProgramsProtocols DocumentationResearch DesignServicesStrategic PlanningUnited States National Institutes Of Health